Impact of Direct Clinical Pharmacist Intervention on Achievement of Blood Pressure Control at a Federally Qualified Health Center Within a Medically Underserved Area.

IF 2.5 Q1 PRIMARY HEALTH CARE
Bethany Maegan Lamb, Evie C Floyd, Reagan K Barfield, Janet V Goff, Tate Owens, Miranda McGee, Joseph Magagnoli, Whitney D Maxwell
{"title":"Impact of Direct Clinical Pharmacist Intervention on Achievement of Blood Pressure Control at a Federally Qualified Health Center Within a Medically Underserved Area.","authors":"Bethany Maegan Lamb, Evie C Floyd, Reagan K Barfield, Janet V Goff, Tate Owens, Miranda McGee, Joseph Magagnoli, Whitney D Maxwell","doi":"10.1177/21501319251380623","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous publications have demonstrated the benefits of pharmacist involvement in hypertension management, including in rural health care settings. Unlike many of the previous studies that evaluated pharmacist interventions occurring in collaboration with physicians, this study uniquely assessed the impact of pharmacist-led interventions under a collaborative practice agreement (CPA) on hypertension outcomes in a rural, medically underserved federally qualified health center (FQHC) in the southeastern U.S.</p><p><strong>Objectives: </strong>To evaluate the effectiveness of direct pharmacist intervention under a CPA compared to physician-only standard care in achieving blood pressure (BP) control. Secondary outcomes included all-cause hospitalization rates and adherence to antihypertensive medications.</p><p><strong>Methods: </strong>This retrospective, single-center observational study included adult patients with hypertension seen by either a clinical pharmacist or a primary care provider over a 3-month period. Primary outcomes were the proportion of patients reaching target systolic and/or diastolic BP and the median time in days to control. Secondary outcomes included all-cause hospitalizations and changes in antihypertensive medication adherence, measured by proportion of days covered (PDC).</p><p><strong>Results: </strong>Among 159 patients, those managed by pharmacists achieved significantly faster BP control (SBP: 49 days vs 182 days, <i>P</i> < .0001; DBP: 146 days vs 160 days, <i>P</i> = .0061). Combined SBP/DBP control was also achieved more quickly (160 days, <i>P</i> < .0001), despite higher initial BP levels. Notably, 0% of patients in the pharmacist group were hospitalized, compared to 10% in the physician-only group (<i>P</i> = .0065). Medication adherence improved, with average PDC rising from 72.5% to 80.2%, and 70.4% of patients reaching ≥80% adherence by study end.</p><p><strong>Conclusions: </strong>Pharmacist-led hypertension management under a CPA significantly improves BP control, time to goal, medication adherence, and reduces hospitalizations compared to physician-only care in a rural, underserved FQHC setting.</p>","PeriodicalId":46723,"journal":{"name":"Journal of Primary Care and Community Health","volume":"16 ","pages":"21501319251380623"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495195/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Primary Care and Community Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21501319251380623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Previous publications have demonstrated the benefits of pharmacist involvement in hypertension management, including in rural health care settings. Unlike many of the previous studies that evaluated pharmacist interventions occurring in collaboration with physicians, this study uniquely assessed the impact of pharmacist-led interventions under a collaborative practice agreement (CPA) on hypertension outcomes in a rural, medically underserved federally qualified health center (FQHC) in the southeastern U.S.

Objectives: To evaluate the effectiveness of direct pharmacist intervention under a CPA compared to physician-only standard care in achieving blood pressure (BP) control. Secondary outcomes included all-cause hospitalization rates and adherence to antihypertensive medications.

Methods: This retrospective, single-center observational study included adult patients with hypertension seen by either a clinical pharmacist or a primary care provider over a 3-month period. Primary outcomes were the proportion of patients reaching target systolic and/or diastolic BP and the median time in days to control. Secondary outcomes included all-cause hospitalizations and changes in antihypertensive medication adherence, measured by proportion of days covered (PDC).

Results: Among 159 patients, those managed by pharmacists achieved significantly faster BP control (SBP: 49 days vs 182 days, P < .0001; DBP: 146 days vs 160 days, P = .0061). Combined SBP/DBP control was also achieved more quickly (160 days, P < .0001), despite higher initial BP levels. Notably, 0% of patients in the pharmacist group were hospitalized, compared to 10% in the physician-only group (P = .0065). Medication adherence improved, with average PDC rising from 72.5% to 80.2%, and 70.4% of patients reaching ≥80% adherence by study end.

Conclusions: Pharmacist-led hypertension management under a CPA significantly improves BP control, time to goal, medication adherence, and reduces hospitalizations compared to physician-only care in a rural, underserved FQHC setting.

临床药师直接干预对医疗服务不足地区联邦合格医疗中心血压控制的影响。
背景:以前的出版物已经证明药师参与高血压管理的好处,包括在农村卫生保健机构。与以往许多评估药剂师与医生合作干预的研究不同,本研究独特地评估了在合作实践协议(CPA)下药剂师主导的干预对美国东南部农村医疗服务不足的联邦合格健康中心(FQHC)高血压结局的影响。评估在CPA下直接药剂师干预与仅医生标准护理在实现血压(BP)控制方面的有效性。次要结局包括全因住院率和抗高血压药物依从性。方法:这项回顾性、单中心观察性研究纳入了由临床药师或初级保健提供者在3个月内就诊的成年高血压患者。主要结局是达到目标收缩压和/或舒张压的患者比例和控制的中位时间(天)。次要结局包括全因住院和抗高血压药物依从性的变化,以覆盖天数比例(PDC)衡量。结果:159例患者中,由药师管理的患者血压控制明显更快(收缩压:49天vs 182天,P P = 0.0061)。联合收缩压/舒张压控制也更快(160天,P = 0.0065)。药物依从性改善,平均PDC从72.5%上升到80.2%,研究结束时70.4%的患者达到≥80%的依从性。结论:在农村服务不足的FQHC环境中,与只接受医生治疗相比,CPA下由药剂师主导的高血压管理显著改善了血压控制、达到目标的时间、药物依从性,并减少了住院率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
2.80%
发文量
183
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信